References
Morton DL, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.
Zagarella S. Sentinel lymph node biopsy still provides no benefits for patients with melanoma. Am J Dermatopathol. 2020;42(7):481–3.
Gershenwald JE, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer, eighth-edition cancer staging manual. CA Cancer J Clin. 2017;67:472–92.
Fonseca IB, et al. Sentinel node status is the most important prognostic information for clinical stage IIB and IIC melanoma patients. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08959-9.
Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173–80.
Acknowledgment
We acknowledge Prof. Francisco Belfort, MD, PhD, for his valuable insights on these reflections.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bertolli, E., Calsavara, V.F. ASO Author Reflections: Sentinel Node Biopsy—Retirement Will Have to Wait. Ann Surg Oncol 27, 4141–4142 (2020). https://doi.org/10.1245/s10434-020-08962-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08962-0